Suppr超能文献

经内镜超声引导下胆管引流术用于经乳头进一步干预被判定为不可能或无效的恶性肝门部胆管狭窄。

EUS-guided Biliary Drainage for Malignant Perihilar Biliary Strictures after Further Transpapillary Intervention Has Been Judged to Be Impossible or Ineffective.

作者信息

Kanno Yoshihide, Ito Kei, Koshita Shinsuke, Ogawa Takahisa, Masu Kaori, Kusunose Hiroaki, Sakai Toshitaka, Masaki Yoshiharu, Murabayashi Toji, Hasegawa Sho, Kozakai Fumisato, Horaguchi Jun, Matsuo Hidenori, Noda Yutaka

机构信息

Sendai City Medical Center, Japan.

Natori Chuo Clinic, Japan.

出版信息

Intern Med. 2017 Dec 1;56(23):3145-3151. doi: 10.2169/internalmedicine.9001-17. Epub 2017 Oct 11.

Abstract

Objective Patients with perihilar malignancy often develop recurrence of infectious cholangitis, which makes further transpapillary intervention extremely difficult. As endoscopic ultrasound (EUS)-guided biliary drainage (EUS-BD) of an intrahepatic bile duct is a possible option for additional intervention, the aim of this study was to estimate the feasibility of such intervention. Methods and Patients Patients who had undergone EUS-BD after further transpapillary intervention was deemed impossible or ineffective were investigated in this study. Those who had not received previous interventions via the papilla were excluded. Procedure-related adverse events, clinical efficacy, and time to recurrence of jaundice or infectious cholangitis transthyretin (TTR) were evaluated. Results Seven patients were eligible for the study between 2007 and 2016 (7 men; mean age, 77 years; 4 with perihilar cholangiocarcinoma and 3 with intrahepatic cholangiocarcinoma). No procedure-related adverse events were observed. EUS-BD was clinically effective and enabled hospital discharge in 4 patients (57%). The TTR in these 4 clinically effective patients was 43, 105, 118, and 147 days after the procedure (median, 112 days). Conclusion EUS-BD was found to be safe and often effective in patients in whom additional transpapillary intervention had become difficult, although its efficacy was limited to a short period.

摘要

目的

肝门部恶性肿瘤患者常发生感染性胆管炎复发,这使得进一步的经乳头介入治疗极为困难。由于肝内胆管的内镜超声(EUS)引导下胆管引流(EUS-BD)是一种可能的额外介入选择,本研究的目的是评估这种介入的可行性。

方法与患者

本研究调查了在经乳头介入治疗被认为不可能或无效后接受EUS-BD的患者。排除那些未曾通过乳头进行过先前介入治疗的患者。评估了与操作相关的不良事件、临床疗效以及黄疸或感染性胆管炎转甲状腺素蛋白(TTR)复发的时间。

结果

2007年至2016年间有7名患者符合研究条件(7名男性;平均年龄77岁;4例肝门部胆管癌,3例肝内胆管癌)。未观察到与操作相关的不良事件。EUS-BD临床有效,4例患者(57%)得以出院。这4例临床有效的患者术后TTR分别为43、105、118和147天(中位数为112天)。

结论

尽管EUS-BD的疗效仅限于短时间,但发现在经乳头介入治疗变得困难的患者中,EUS-BD是安全且常有效的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验